Furthermore, Bcl-2 targeting reduces oxidative phosphorylation in AML cells [87], inhibits the electron transport chain and decreases energy production but increases cellular reactive oxygen species and thereby decreases the glutathione levels [88]. The gene discussed is BCL2; the disease is acute myeloid leukemia.